MKI67 and breast carcinoma: Yet, as shown by different trials and a recent publication of the International Ki67 in Breast Cancer Working Group (IKWG), the analytical validity and clinical utility of Ki67 is limited due to technical procedures and the diverging interrater reliability [16].